The technology, experimental approaches, and bioinformatics that support proteomic
research are evolving rapidly. The application of these new capabilities to the study of …

Investigation of the human specimens is an essential element for understanding the
pathogenesis of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's …

Biomarkers for neurodegenerative disorders are essential to facilitate disease diagnosis,
ideally at early stages, monitor disease progression, and assess response to existing and …

Neurodegenerative disorders are characterized by neuronal impairment that eventually
leads to neuronal death. In spite of the brain's known capacity for regeneration, lost neurons …

Dementias are prevalent brain disorders in the aged population. Dementias pose major
socio‐medical burden, but currently there is no cure available. Novel proteomics …

Recent advances within the field of proteomics, including both upstream and downstream
protocols, have fuelled a transition from simple protein identification to functional analysis. A …

There is an urgent need for novel biomarkers that can be used to improve the diagnosis,
predict the disease progression, improve our understanding of the pathology or serve as …

Neurodegenerative diseases are a major health concern worldwide. Diseases such as
Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral …

Alzheimer's disease, Parkinson's disease, prion diseases, schizophrenia, and multiple
sclerosis are the most common nervous system diseases, affecting millions of people …

The clinical diagnosis of major neurodegenerative disorders, eg Alzheimer's disease,
Parkinson's disease, and dementia with Lewy body, remains unsatisfactory based on current …